Concepedia

Kevin L. Best

KL

9

Publications

407

Citations

9

H-Index

1982

Active since

Affiliations

Eli Lilly (United States)(Current)

Kevin L. Best is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1982–1995

9

Publications

9

A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.

David T. Wong, Penny G. Threlkeld, Kevin L. Best et al. · Journal of Pharmacology and Experimental Therapeutics · 1982 · 192 citations · Full text

Experimental induction of neoplasia in the accessory sex organs of male Lobund-Wistar rats.

D. M. Hoover, Kevin L. Best, B K McKenney et al. · PubMed · 1990 · 46 citations

, , +15

Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the rat

Gerald F. Smith, Blake Lee Neubauer, Jacqueline L. Sundboom et al. · Thrombosis Research · 1988 · 37 citations

, , +14

Endocrine and antiprostatic effects of raloxifene (LY156758) in the male rat

Blake Lee Neubauer, Kevin L. Best, James A. Clemens et al. · The Prostate · 1993 · 34 citations

Raloxifene (LY156758) produces antimetastatic responses and extends survival in the paiii rat prostatic adenocarcinoma model

Blake Lee Neubauer, Kevin L. Best, David F. Counts et al. · The Prostate · 1995 · 30 citations

, , +15

Rows per page

1–5 of 9